The study was conducted in fifty four active disease SLE patients (SLEDAI score>5 p = 0.433).
I. Background
Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease that occurs more frequently in the last decade. The etiology and pathogenesis of SLE remains unclear, however evidences suggest that deviation function of T cells, B cells, monocytes and regulatory T cells ultimately lead to systemic inflammation and tissue damages [1, 2] . Although the 10-year life expectancy of SLE patients has risen significantly to 90% in developed countries, a study by Handono showed that life expectancy of SLE patients in Indonesia remains low, 70% within 5-year and 55% with in 10-year [3] .
A recent study concluded an association between the onset of autoimmune disease with vitamin D deficiency [4] . A high percentage of these patients have been found to live in continental/temperate climate countries [5] . Vitamin D contributes to the regulation of immune responses in several ways by inhibiting monocyte differentiation into dendritic cells (DC), inhibiting DC maturation or differentiation, and maintaining the condition of immature DC (iDC) [6] . Furthermore, it has been reported that vitamin D inhibits the activation of T cell-dependent DC [7] , reduces the secretion of Th1 and Th2 cytokines and induces the development of regulatory T cells (Treg) [8] .
It has been known that DC maturation markers are surface molecular expression of CD11c+/CD86/CD40/CD83. Monocytes (moDC) that develope into DC are characterized by the expression of CD11c+ and lower expression of CD86/CD40/CD83 co-stimulatory molecules. However, expression of the molecules will increase in immature DC (iDC) and the highest expression occurred in mature DC (mDC).
Mature dendritic cells play a major role as Antigen Presenting Cells (APC) that initiate professial response to cellular immunity and humoral immunity. In addition, mDC plays a role in maintaining peripheral tolerance, which is a mechanism to prevent autoimmunity such as SLE [9] .
It has been shown that the deviation in DC function results in increased of T cells activation. The secretion of pro-inflammatory and anti-inflammatory cytokines has been reported to increase, which indicates the abnormalities of T reg functions. This condition is associated with the onset of clinical manifestations of SLE [10, 11] .
The clinical manifestation of SLE patients in Indonesia was different from those of Caucasian. Indonesian SLE patients showed a more severe and relatively more patients with anti-dsDNA and photosensitive manifestation [3] . In this study, we aimed therefore to determine the association of vitamin D level, DC maturation markers and Th1 and Th2 cytokine expression in Indonesian SLE patients. The level of vitamin D was considered as normal when the concentration >30 ng/ml [5] .
Furthermore, randomly selected ten SLE patients with hypovitamin D and ten healthy controls with normovitamin D, used to analyse the exspression of CD11c+/CD86/CD40/ CD83, IL-4 and IFN-γ molecules by Flowcytometry (FC).
II.
Research Methods
Subjects and study design
The study conducted in fifty four female SLE patients age 31,12±9.99 (diagnosed according to the American College of Rheumatology Criteria, 1992), in active disease state (SLEDAI score>5), and not consuming vitamin D supplements. Patients are gathered from outpatient clinics and inpatient Department of Internal Medicine, Dr Saiful Anwar Hospital Malang, Indonesia. Twenty three healthy female volunteers mathced for age 32.91±5.92, and ethnicity serves as controls. This study was approved by the Ethics Committee of the University of Brawijaya, Faculty of Medicine Malang and informed consent was obtained from all participants.
Sampel preparation
Three milliliters of peripheral venous blood were collected from each participants. Serum was isolated, stored in a -80 ° C until used to measure the concentration of vitamin D (25(OH)D3) by ELISA in accordance with the manufacturer's instructions (Cusabio, USA). All samples were assayed in duplicate. The level of vitamin D was considered as normal when the concentration >30 ng/ml [5] . Furthermore, randomly selected ten SLE patients with hypovitamin D and ten healthy controls with normovitamin D, used to analyse the exspression of CD11c+/CD86/CD40/ CD83, IL-4 and IFN-γ molecules by Flowcytometry (FC).
Analysis of CD11c+/CD86/CD40/CD83 molecules expression on moDC, iDC and mDC
Peripheral blood mononuclear cells (PBMC) were obtained from twenty milliliters of heparinized peripheral blood by Ficoll-Hypage density centrifugation (1600 rpm/min for 30 minutes at room temperature). PBMC were then isolated and washed twice in phosphate buffered saline (PBS). Furthermore, PBMC were suspended at a density of 2 x 10 6 cells / ml in Roswell Park Memorial Institute/RPMI media 1640 (SigmaAldrich, USA) with L-Glutamine and 10% heat in activated Fetal Calf Serum (Gibco, USA), supplemented with 100 ug/ml streptomycin, 100 U/ ml penicillin (Sigma-Aldrich, USA). Surface staining were performed with PE anti-human CD11c+ antibody, PerCP anti-human CD86 antibody, FITC anti-human CD83 antibody, FITC antihuman CD40 antibody (all from Biolegend, USA). moDC were recognized as cells expressing CD11c+/CD86/CD40/CD83 on the day 0.
In order to indentify iDC, PBMC were cultured in TC plate 96 well, aliquots of 5 x 10 5 cells / well with 150 ml medium II (50 ng / ml GM-SCF (Gibco, USA) and 100 ng/ml IL-4 (Prospec, USA), incubated 6 days of 37ºC, 5% CO2. Replaced the medium every 3 days. At the end of day 6, cells were triple stained with monoclonal antibodies for 30 minutes, washed in PBS and a the expression of CD11c +/CD86/CD40/CD83 were analyzed by FC.
To identify mDC, further incubation was required for 2 days. Culture medium was replaced with 150 ml medium III (50 ng / ml GM-CSF (Gibco, USA) with 100 ng/ml IL-4 and 50ng/ml TNF-alpha (all from Prospec, USA). At the end of day 8, cells were triple stained with monoclonal antibodies and the expression of CD11c+/CD86/CD40/ CD83 were analyzed by FC.
Stimulation of peripheral blood lymphocyets and detection of cytokines.
PBMC were resuspended in 150 ml RPMI 1640 with 10% human AB serum and then preincubated with β mercapto ethanol (2x 10 6 cells/well), 30μ/ml αCD3 and 2μl/ml IL-2 for 3 days at 37° C and 5% CO2. Furthermore, PBL were incubated with PMA (2 ml PMA + 8 ml RPMI) for 6-8 hours ionomycin (0,7 μg/ml) in the presence of brefeldin-A (10 μg/ml). Cells were labelled with FITC-CD4 and incubated for 20 minutes, fixed and incubated for further 30 minutes. Furthermore, intra-cellular staining were performed with monoclonal antibodies : PE-IFNγ (BD Bioscience) and PerCP-IL-4, incubated for 20 minutes and were wahsed in Perm/Wash buffer. Finally samples were analyzed by FC. Cytokine expressing CD4+ cells were classified as Th1 (producing IFNγ) and Th2 (producing IL-4).
Statistical Analysis
Statisical analysis were performed with SPSS 16 version. Differences levels of vitamin D between SLE patients and the control group were determined by indipendent t-test. The differences in the differentiation of DCs (moDC, iDC, mDC) and the expression of IL-4 and IFN-γ in the two groups were analyzed with independent T test. Correlation of vitamin D level with the differentiation of DC, Th1/Th2 cytokine production were analyzed by Spearman test ; p value <0.05 was considered significant.
III. Results
Characteristics of subjects There were no differences of age in the SLE patients and healthy control subject (31.12 ± 9.99 and 32.91 ± 5.92 years, p>0.05). Nephritis was the most clinical symptom in SLE patients (50 %), followed by arthritis, photosensitivity and hematological abnormalities. The mean level of anti-dsDNA was 142.57 ± 79.73 IU/ml and 70.3% of SLE patients showed high levels of anti-dsDNA (>92 IU/ml). The characteristics of the study subjects are summarized in Table 1 . 
Vitamin D levels in SLE patients and healthy control
The mean level of vitamin D in SLE patients was 22.80±16.23 ng/mL (2.1-50.4 ng/mL), with 92.5% of the patients showed hypovitamin D. However, the mean level of vitamin D in healthy controls was 35.15±7.61 ng/mL (18.9-48.30ng/mL) with only four subjects (17.3%) had vitamin D deficiency. There were significant difference between the level of vitamin D in SLE patients and healthy control (p =0.00), (Fig. 1 ). percentage of mDC (cells expressing CD11c+/CD86/CD40 on the day 8) in SLE patients were slightly higher compared with the healthy controls (14.93 ±7.83% and 12.97±4.38% ; p =0.229), (Fig 2) .
Figure 2:
The percentage of DC expressing CD11c+/ CD86/CD40 in healthy controls and SLE patients. moDC were analyzed on day 0, iDC analyzed on the day 6 and mDC analyzed on the day 8. Extracelular staining with PE-anti-CD11c+, PerCP-anti-CD86 and FITC anti-CD40 antibodies.
Differentiation of DC (moDC, iDC and mDC) expressing CD11c+/CD86/CD83 molecules in SLE patients and healthy controls
The percentage of moDC (cells expressing CD11c+/CD86/CD83 on the day 0) were similar between SLE patients and healthy controls (6.73±5.43% vs6.23±4.01%, p>0.05). While the number of iDC (cells expressing CD11c+/CD86/CD83 on the day 6) were significantly higher in SLE patients than healthy controls (21.96±4.94% vs 9.69±5.78%, p=0.021). The percentage of mDC (cells expressing CD11c+/CD86/CD83 on the day 8) were also similar between two groups (20.59±9.55% and 12.54±5.85%), with only trend towards a higher percentage in the SLE patients (p =0.258) (Fig 3) .
Figure 3:
The percentage of DC expressing CD11c+/CD86/CD83 in healthy controls and SLE patients. moDC were analyzed at the day-0, iDC were analyzed at day-6, mDC were analyzed at day-8. Extracelular staining with PE anti-CD11c+, PerCP anti-CD86 and FITC anti-CD83 antibodies.
Differences of IFNγ and IL-4 expression and IFNγ/IL-4 ratio in SLE patients and healthy controls
The results of this study showed the percentage of Th1 cells producing IFN-γ in SLE patients tend to be higher than those of the healthy controls (9.08 ± 6.52 vs 13.19% ± 9.44% ; p = 0.062). The percentage of Th2 cells producing IL-4 in SLE patients also tend to be higher than in healthy control (5.05±8.53 vs 3.35±5.31 ; p = 0.058). While the ratio of IFN-γ/IL-4 in SLE patients were similar in two groups (1.29 and 1.20 ; p = 0.520), (Fig 4) . 
The correlation of serum level of Vitamin D with DC differentiation and IFNγ/IL4 expression
The result of our study noticed negative correlation between vitamin D levels and the expression of CD11c+/CD86/CD40/CD83 at iDC and mDC (Table 2) . However, there were no correlation of vitamin D levels and IFN-γ (r = 0.069, p = 0.712) and IL-4 production (r = 0.146, p = 0433). [12] . Wozniacka et al also reported that concentration of serum 25(OH)D in SLE patients significantly decreased during the summer season compared to the control group [13] . Cohort studied by Toloza et al showed there were vitamin D insufficiency in female SLE patients, with the prevalence of 66.7% sub optimal levels of 25(OH)D, and 17.9 % deficiency [14] .
It still cannot be determined whether the lower levels of vitamin D was caused by or an effect of SLE. Hypovitamin D may be the cause of SLE, as supported by evidence that vitamin D has a role in the regulation of the immune system that can prevent autoimmunity [15] , thus low levels of vitamin D may disrupt the regulation of the immune system. The involvement of vitamin D in the immune response demonstrates evidence that 1) the vitamin D receptors (VDR) are expressed in various of immune system cells, including monocytes, macrophages, activated T and B cells [16] . 2) Vitamin 1,25 (OH)2D3 can regulate the activity of T cells either directly or indirectly through modulation of DC as APC [4] . 3) When monocytes differentiate into iDC,vitamin 1,25 (OH)2D3 has a role in improving the ability to capture and bind the microbial antigens that enhance the immune response initiation [17] . 4). Vitamin D deficiency leads to the loss of immune response and tolerance, and add vitamin D invitro that can restore the abnormal immune regulation of SLE patients [7] . Further evidence suggests that SLE patients have higher risks of hypovitamin D, this is likely due to the manifestation of photosensitivity, causing SLE patients to avoid direct exposure to sunlight. Other predisposition factors include the use of sunscreens, the effect of corticosteroid and chloroquine therapy, renal impairment and the presence of antibodies anti-vitamin D [7] .
Different numbers of moDC, iDC and mDC expressing CD11c+/CD86/CD40/CD83 in SLE patients with hypovitamin D and healthy control
Dendritic cells are professional APCs that initiate innate and adaptive immune responses, in particular play an important role in the regulation of T cell activation and proliferation [18] . Dendritic cells also play a role in inducing immune tolerance both central and peripheral [19] . The ability of DCs to express co-stimulatory molecules (CD40/CD83) determine their capacity as either cells that maintain tolerance or activator cells. Generally, tolerance is initiated when DC still in immature condition, whereas the initiation of the adaptive immune response requires an effective signal of mDC [18] . Thus it can be concluded that DC expresses CD40/CD83 is highest when in the mature condition. These studied looked differences in the molecular expression of CD11c+ and CD86/CD40/CD83 co-stimulator molecules between moDC, iDC and mDC in the control group and SLE patients with hypovitamin D. Analysis of surface markers CD40 and CD83 are performed separately due to equipment limitations.
These results indicated that the expression of CD11c+/CD86/CD40/83 iDC SLE patients were significantly higher than the control group. This elevated expression of CD11c+/CD86/CD40/CD83 in iDC cells, suggesting that DC has been able to activate T cells even in an immature state. This can be seen as an unfavorable situation, as there will be an expected increase in T cell activation.
Increased expression of CD86 is associated with increased DC migration to lymphoid organs, thus stimulating T cells to increase expression of CD40, which is a ligand for the activation of T cells, demonstrating the ability of DC as a highly efficient APC. Decker et al reports similar results that SLE patients, in particular those in iDC stages showing, "Over-express" of CD86 [20] . Furthermore, Nie et al also reports the increased expression of CD40 and CD86 in SLE patients in iDC stages [21] . This could explain how peripheral tolerance ability of SLE patients may be impaired and lead to T cell auto-reactivity.
Expression of CD83 is a cell surface marker, mostly found in mDC cells. Function of CD83 molecules has not been clearly defined; however CD83 plays an important role during cells interaction. CD83 enhances the capacity of DC to induce an immune response. Ding et all finds that mDC SLE patients show a high expression of CD80 and CD86 accompanied by increased ability to activate T cells, although the expression of CD83 it self decreases (18) . This notion is also supported by Crispin and Varella's reasearch, in which the SLE serum contains several factors capable of inducing phenotypic changes and function of dendritic cells, particularly in active SLE patients [10] .
In addition to vitamin D, other factors affecting the increased expression of co stimulatory molecules on DC are a) the presence of infection b) the presence of soluble factors (antibodies or acute phase protein) in the serum of SLE patients that can trigger DCl maturation and c) increase the apoptotic cells in SLE, induces maturation of DC. The latest data shows that apoptotic blebs induce maturation of myeloid DC [11] . DC, a professional APC serves as the main target of active metabolite of vitamin D, 1,25(OH)2D3. The known effects of 1,25 (OH)2D3 inhibits monocyte differentiation into DCs and inhibits DC maturation process [7] , and also further maintains it in a state of immaturity (6), in addition 1,25 (OH)2D3 also promotes DC to apoptosis. This results in the inhibitory effect of T cell activation and induces alloreactive T cells into hyporesponsive ones [22] .
The results of the study showed that SLE patients with hypovitamin D had iDC higher than healthy controls, and there was negative correlation between vitamin D levels and differentiation state of DC expecially the expression of CD11c+/CD86/CD40/CD83 in iDC and mDC stages. Several in vitro studies have reported that 1,25(OH)2D3 is negatively correlated with expression of CD40, CD80, CD86 co-stimulatory molecules, inhibit the production of IL-12 and increase the production of IL-10, resulting in a reduced T cell activation DC derived from monocyte-derived dendritic cells (MDDCs) in human peripheral blood or in mouse bone marrow derived dendritic cells, both showing consistent results [17] . Furthermore, Mathieu and Adorini show significant results in therapy 1,25 (OH) 2D3 both in vitro and in vivo that reduces the expression of MHC class II, costimulatory molecules (CD80, CD86, CD40) and lower the maturation process of dendritic cells (CD83) [23] .
Differences in number of Th1 and Th2 cells expressing IFNγ and IL-4 in SLE patients and healthy controls
The results of this study indicate that the percentage of Th1 producing IFN-γ cells and the Th2 producing IL-4 cells tend to be higher in SLE patients than those in the healthy control group. It has been understood that SLE is a prototype of autoimmune disease with the dominance of Th2 activity by hyperactivity B cell. However, the result of this study shows that actvity Th1 cells increases, this is likely due to compensation by excessive Th1 cells that inhibits the activity of Th2 cells, which subsequently leads to chronic systemic inflammation (4, 24, 25) . These results are consistent with Sayed et al, who demonstrate that IFN-γ levels are significantly higher in SLE patients compared with the control group (26) . Similarly, the ratio of IFN-γ / IL-10, IFN-γ / IL4, TNF / IL-10, and TNF/IL-4, indicates the dominant participation of Th1 more than Th2. Active metabolite of vitamin D, 1,25-dihydroxy vitamin D (1,25 (OH) 2D3), can alter T cell compartment to be more anti-inflammatory and in a state regulated by Th1 and Th17 cells that inhibits and increases Th2 and Treg cells (26) . In a case where vitamin D levels are low, the function will be impaired there by inhibition of T cells tend to be inflammatory.
V. Conclusion
Vitamin D (1,25(OH)2D3) serum concentration is significantly lowerin Indonesian SLE patients compared with healthy controls. The low concentration was related to higher expression of CD11c+/CD86/ CD40/CD83 iniDC cells and higher secretion of Th1 cytokines (IFN-γ) and Th2 cytokines (IL-4). However, the ratio of the cytokines was not significantly different between SLE patients and healthy controls.The use of vitamin D in SLE patients needs to be examined further.
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